Literature DB >> 17334722

Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological features.

Takeshi Fujii1, Tetsuya Nakamura, Aikichi Iwamoto.   

Abstract

Pneumocystis pneumonia (PCP) remains the most common opportunistic infection in patients with acquired immunodeficiency syndrome (AIDS). Familiarity with the clinical features of PCP is crucial for prompt diagnosis, even if the patient is unaware of their HIV serostatus. We describe herein the clinical features of 34 episodes in 32 patients with AIDS-associated PCP and review the existing literature. As for symptoms, the frequency of fever, cough, and dyspnea was 74%, 74%, and 65%, respectively, and the complete triad was present in only 14 of the 34 episodes on first examination. Median duration from onset of symptoms until diagnosis was 3 weeks, and AIDS-associated PCP tended to take an insidious clinical course. Although laboratory findings were generally nonspecific, measurement of beta-D-glucan levels in the serum or plasma was highly useful in the diagnosis of PCP. All but 1 of the patients showed beta-D-glucan levels higher than the cutoff value (median, 147 pg/ml; range, 5-6920 pg/ml). Typical radiographic features of PCP are bilateral, symmetrical ground-glass opacities, but a wide variety of radiographic findings were observed. In our patients, high-resolution computed tomography (HRCT) of the lung showed ground-glass opacities sparing the lung periphery (41% of episodes) or displaying a mosaic pattern (29%), or being nearly homogeneous (24%), ground-glass opacities associated with air-space consolidation (21%), associated with cystic formation (21%), associated with linear-reticular opacities (18%), patchily and irregularly distributed (15%), associated with solitary or multiple nodules (9%), and associated with parenchymal cavity lesions (6%).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334722     DOI: 10.1007/s10156-006-0484-5

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  32 in total

Review 1.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

2.  Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography.

Authors:  Yoshie Kunihiro; Nobuyuki Tanaka; Reo Kawano; Toshiaki Yujiri; Makoto Kubo; Kazuhiro Ueda; Toshikazu Gondo; Taiga Kobayashi; Tsuneo Matsumoto
Journal:  Eur Radiol       Date:  2019-05-06       Impact factor: 5.315

Review 3.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

4.  Pneumocystis Pneumonia - A Novel Complication in a Non-HIV Dengue Patient.

Authors:  Swapndeep Singh Atwal; Swapnil Puranik; Shibani Mehra; Umesh Chandra Garga
Journal:  J Clin Diagn Res       Date:  2014-09-20

5.  Apical Pneumocystis jiroveci as an AIDS defining illness: A case report illustrating a change in the paradigm.

Authors:  Kyle Pfeifer; Vivek Kalra; Adeniran Adebowale; Manisha Juthani-Mehta; Myung Soo-Shin
Journal:  J Radiol Case Rep       Date:  2014-11-30

6.  Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii.

Authors:  Andreas A Rostved; Monica Sassi; Jørgen A L Kurtzhals; Søren Schwartz Sørensen; Allan Rasmussen; Christian Ross; Emile Gogineni; Charles Huber; Geetha Kutty; Joseph A Kovacs; Jannik Helweg-Larsen
Journal:  Transplantation       Date:  2013-11-15       Impact factor: 4.939

7.  Usefulness of 1,3 Beta-D-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia.

Authors:  Tobias Lahmer; Clarissa Prazeres da Costa; Jürgen Held; Sebastian Rasch; Ursula Ehmer; Roland M Schmid; Wolfgang Huber
Journal:  Mycopathologia       Date:  2017-04-04       Impact factor: 2.574

8.  Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.

Authors:  Paul E Sax; Lauren Komarow; Malcolm A Finkelman; Philip M Grant; Janet Andersen; Eileen Scully; William G Powderly; Andrew R Zolopa
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

9.  Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Florence Persat; Stéphane Ranque; Francis Derouin; Annie Michel-Nguyen; Stéphane Picot; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

10.  Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review.

Authors:  Wei-Jie Li; Ya-Ling Guo; Tang-Juan Liu; Ke Wang; Jin-Liang Kong
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.